Sinew Pharma Inc. (TPEX:6634)
38.85
+0.75 (1.97%)
Feb 11, 2026, 1:23 PM CST
Sinew Pharma Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
2.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 328.00K | -5.90M | -94.73% |
| Dec 31, 2021 | 6.23M | 5.77M | 1,248.27% |
| Dec 31, 2020 | 462.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.13B |
| Apex Biotechnology | 1.96B |
| SYN-TECH Chem. & Pharm. | 1.29B |
| Synbio Tech | 1.00B |
| 3D Global Biotech | 324.87M |
| G&E Herbal Biotechnology | 311.78M |
| HeXun Biosciences | 290.83M |
| Sunny Pharmtech | 290.18M |